Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended May 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for so...

Analysts have been downgrading Walgreens shares, but they still see a lot of potential upside. The stock trades at a low earnings multiple and it's right around its book value.

London's stock market suffered another blow when the Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A) revealed it had axed plans to list the British high street pharmacy chain. Hopes for a UK flo...

Walgreens-backed CityMD will pay $12.04 million to settle Covid fraud allegations brought by the Department of Justice. For two years of the pandemic, CityMD allegedly obtained fraudulent governmen...

Shares of Walgreens Boots Alliance (WBA) fell over 3% Wednesday after the pharmacy retailer announced plans to join the growing list of retailers cutting prices to win back customers who have chang...

Walgreens Boots Alliance Inc. said Wednesday it was continuing to lower prices as part of its “Summer of Savings” promotional campaign, this time on more than 1,300 products — but that announcement...

Walgreens Boots Alliance (WBA) concluded the recent trading session at $16.03, signifying a +0.5% move from its prior day's close.

Investors are optimistic about Walgreens Boots (WBA), led by strategic alliances and new product launches.

U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC).

Walgreens saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers for the Boots business. [1] Boots is a UK-based drugstore chain, and it could be valu...

Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than over-the-counter Narcan nasal spray.

Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.

A media report stated that the pharmacy-chain operator is in talks to sell a core asset. At one point, that business unit apparently could have fetched nearly $9 billion.

Walgreens Boots Alliance (WBA) shares jumped in intraday trading Monday following a report that the big drugstore chain has been reaching out to potential buyers of its British-based Boots unit.

Walgreens Boots Alliance is once again attempting to sell its Boots pharmacies in the United Kingdom as the company chief executive officer Tim Wentworth and his new management team review the comp...